Dr Sherin Bakhashab Rosie Barber Josie O'Neill Dr Catherine Arden Dr Jolanta Weaver et al. | Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression | 2024 |
|
Dr Sherin Bakhashab Josie O'Neill Rosie Barber Dr Catherine Arden Dr Jolanta Weaver et al. | Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy | 2024 |
|
Jason Phowira Nicholas Vennart Dr Jolanta Weaver
| Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up | 2022 |
|
Jason Phowira Dr Sherin Bakhashab Anuradha Doddaballapur Dr Jolanta Weaver
| Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function | 2022 |
|
Nicholas Vennart Dr Jolanta Weaver Dr Salman Razvi
| The prevalence and significance of non-uniform thyroid radio-isotope uptake in patients with Graves’ disease | 2022 |
|
Jason Phowira Dr Fahad Ahmed Dr Sherin Bakhashab Dr Jolanta Weaver
| Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study | 2022 |
|
Dr Sherin Bakhashab Jevi Latief Dr Jolanta Weaver
| MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus) | 2021 |
|
Alice Tamara Jevi Latief Dr Jolanta Weaver
| Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health | 2021 |
|
Sabby Ray Alice Tamara Jevi Latief Dr Sherin Bakhashab Dr Jolanta Weaver et al. | The role of miR-342 in vascular health. Study in subclinical cardiovascular disease in mononuclear cells, plasma, inflammatory cytokines and PANX2 | 2020 |
|
Professor Philip Preshaw Dr John Taylor Dr Katrin Jaedicke Dr Susan Bissett Paiboon Jitprasertwong et al. | Treatment of periodontitis reduces systemic inflammation in type 2 diabetes | 2020 |
|
Dr Arjola Bano Dr Earn Gan Dr Jolanta Weaver Dr Salman Razvi
| Age may influence the impact of TRAbs on thyroid function and relapse-risk in patients with Graves’ disease | 2018 |
|
Dr Fahad Ahmed Dr Sherin Bakhashab INDA Bastaman Dr Rachel Crossland Dr Michael Glanville et al. | Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study | 2018 |
|
Dr Sherin Bakhashab Dr Fahad Ahmed Dr Michael Glanville Dr Jolanta Weaver
| Proangiogenic effect of metformin in endothelial cells is via upregulation of VEGFR1/2 and their signaling under hyperglycemia-hypoxia | 2018 |
|
Dr Andy Colman Dr Jolanta Weaver
| Use of Quick Response (QR) coded bracelets and cards for the improvement of cortisol deficiency/Addison's disease management: an audit of quality of care of the management of steroid deficiency in acute illness | 2018 |
|
Dr Fahad Ahmed Rachel Rider Dr Michael Glanville Dr Salman Razvi Dr Jolanta Weaver et al. | Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study | 2016 |
|
Sherin Bakhashab Dr Fahad Ahmed Dr Jolanta Weaver
| Metformin improves the angiogenic potential of human CD34+cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction | 2016 |
|
Dr Sherin Bakhashab Dr Jolanta Weaver
| Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma | 2016 |
|
Dr Sviatlana Zhyzhneuskaya Dr Jolanta Weaver Dr Salman Razvi
| The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds | 2016 |
|
Dr Daniel West Professor Mark Walker Professor James Shaw Dr Fahad Ahmed Stephanie Wijaya et al. | Inflammation and the acute endothelial progenitor cell response to submaximal running exercise in males with and without Type 1 diabetes | 2015 |
|
Dr Asgar Madathil Dr Kieren Hollingsworth Professor Andrew Blamire Dr Salman Razvi Emerita Professor Julia Newton et al. | Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study | 2015 |
|
Dr Anna Mitchell Katie MacArthur Dr Jolanta Weaver Dr Bijayeswar Vaidya Dr Rebecca Darlay et al. | Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus | 2015 |
|
Professor Mark Walker Dr Fahad Ahmed Stephanie Wijaya Professor James Shaw Dr Jolanta Weaver et al. | The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study | 2015 |
|
Dr Fahad Ahmed Dr Jolanta Weaver
| Metformin improves endothelial progenitor cell number in Type 1 diabetes: MERIT study preliminary report | 2014 |
|
Sherin Bakhashab Dr Fahad Ahmed Dr Jolanta Weaver
| Reference Genes for Expression Studies in Hypoxia and Hyperglycemia Models in Human Umbilical Vein Endothelial Cells | 2014 |
|
Jedrzej Hoffmann Dr Karel Fiser Dr Jolanta Weaver Ian Dimmick Monika Loeher et al. | High-Throughput 13-Parameter Immunophenotyping Identifies Shifts in the Circulating T-Cell Compartment Following Reperfusion in Patients with Acute Myocardial Infarction | 2012 |
|
Dr Salman Razvi Dr Jolanta Weaver Dr Tim Butler Professor Simon Pearce
| Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality | 2012 |
|
Dr Shaikh Abdul Shakoor Dr Ali Aldibbiat Lorna Ingoe Dr Susan Campbell Dr Latika Sibal et al. | Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy | 2010 |
|
Dr Salman Razvi Dr Jolanta Weaver Professor Simon Pearce
| Subclinical thyroid disorders: significance and clinical impact | 2010 |
|
Dr Salman Razvi Dr Jolanta Weaver Professor Simon Pearce
| The Incidence of Ischemic Heart Disease and Mortality in People with Subclinical Hypothyroidism: Reanalysis of the Whickham Survey Cohort | 2010 |
|
Dr Latika Sibal Dr Ali Aldibbiat Dr Sharad Agarwal Crispian Oates Dr Salman Razvi et al. | Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria | 2009 |
|
Dr Jolanta Weaver
| Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study) | 2009 |
|
Dr Akheel Syed Dr Christina Halpin Professor Julie Irving Professor Nigel Unwin Professor Martin White et al. | A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in men | 2008 |
|
Dr Jolanta Weaver
| Classical endocrine diseases causing obesity | 2008 |
|
Dr Jolanta Weaver
| Classical endocrine diseases causing obesity | 2008 |
|
Dr Salman Razvi Dr Jolanta Weaver
| Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ | 2008 |
|
Dr Akheel Syed Dr Chris Redfern Dr Jolanta Weaver
| In vivo and in vitro glucocorticoid sensitivity in obese people with cushingoid appearance | 2008 |
|
Hannah Fraser Professor Philip Preshaw Professor Roy Taylor Dr Jolanta Weaver Dr Rebecca Wassall et al. | Oral Hygiene and Periodontal Health in Type 1 Diabetes Patients | 2008 |
|
Dr Salman Razvi Dr Jolanta Weaver Professor Simon Pearce
| The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis | 2008 |
|
Dr Latika Sibal Dr Ali Aldibbiat Crispian Oates Dr Jolanta Weaver Professor James Shaw et al. | The influence of the presence of retinopathy on the circulating endothelial progenitor cell counts, endothelial function and carotid intima-media thickness in type I diabetes | 2008 |
|
Dr Jolanta Weaver
| Applicability of estimated glomerular filtration rate in stratifying chronic kidney disease | 2007 |
|
Dr Latika Sibal Dr Ali Aldibbiat Dr Jolanta Weaver Dr Salman Razvi Crispian Oates et al. | Endothelial dysfunction and circulating endothelial progenitor cells in young people with type 1 diabetes | 2007 |
|
Dr Latika Sibal Dr Ali Aldibbiat Dr Sharad Agarwal Dr Jolanta Weaver Dr Salman Razvi et al. | Endothelial dysfunction, carotid intima media thickness and circulating endothelial progenitor cells in young people with Type 1 diabetes | 2007 |
|
Dr Jolanta Weaver
| RCT of continuous glucose monitoring devices on HbA(1C) - The MITRE study | 2007 |
|
Dr Salman Razvi Lorna Ingoe Crispian Oates Dr Jolanta Weaver
| The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial | 2007 |
|
Dr Jolanta Weaver
| Use and acceptability of two minimally invasive continuous blood glucose monitors | 2007 |
|
Dr Akheel Syed Professor Julie Irving Dr Chris Redfern Dr Andrew Hall Professor Nigel Unwin et al. | Association of glucocorticoid receptor polymorphism A3669G in exon 9β with reduced central adiposity in women | 2006 |
|
Dr Jolanta Weaver
| Borderline thyroid function tests: so easy to look at, so hard to define | 2006 |
|
Dr Salman Razvi Dr Jolanta Weaver
| Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: The ThyTSQ | 2006 |
|
Dr Jolanta Weaver Dr Salman Razvi
| Dose of anti-thyroid drugs can effect remission in grave's disease | 2005 |
|
Dr Akheel Syed Dr Jolanta Weaver
| Glucocorticoid sensitivity: The hypothalamic-pituitary-adrenal-tissue axis | 2005 |
|
Dr Salman Razvi Lorna Ingoe Dr Jolanta Weaver
| Health status in patients with sub-clinical hypothyroidism | 2005 |
|
Dr Salman Razvi Dr Jolanta Weaver
| Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: A systematic qualitative review | 2005 |
|
Dr Jolanta Weaver
| Obesity, cytokines and the search for beauty | 2005 |
|
Dr Jolanta Weaver Dr Salman Razvi
| The detrimental effect of anti-thyroid drugs on the outcome of radioiodine therapy is not directly due to decreased radioiodine uptake [2] (multiple letters) | 2005 |
|
Dr Akheel Syed Dr Chris Redfern Dr Jolanta Weaver
| Aldosterone revisited | 2004 |
|
Dr Salman Razvi Dr Jolanta Weaver
| Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism | 2004 |
|
Dr Bakri Saeed Dr Andrew Skillen Dr Jolanta Weaver
| Fasting homocysteine levels in adults with type 1 diabetes and retinopathy | 2004 |
|
Dr Akheel Syed Dr Jolanta Weaver
| Insulin resistance and coronary artery disease: Body mass index may have affected results | 2004 |
|
Dr Akheel Syed Dr Jolanta Weaver
| Insulin resistance and coronary artery disease: lean subjects should be used as controls | 2004 |
|
Dr Salman Razvi Dr Elizabeth McIntyre Dr S Wahid Dr Jolanta Weaver
| Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: The Gateshead protocol | 2004 |
|
Dr Salman Razvi Dr Elizabeth McIntyre Dr Jolanta Weaver
| Low failure rate of fixed dose 400 MBq131I with pre-treatment with Carbimazole for thyrotoxicosis; The Gateshead protocol | 2004 |
|
Dr Akheel Syed Professor Julie Irving Dr Chris Redfern Dr Andrew Hall Professor Nigel Unwin et al. | Low Prevalence of the N363S Polymorphism of the Glucocorticoid Receptor in South Asians Living in the United Kingdom | 2004 |
|
Dr Jolanta Weaver
| Metabolic syndrome; a new disease | 2004 |
|
Dr Jolanta Weaver
| Metabolic Syndrome; new disease | 2004 |
|
Dr Jolanta Weaver
| Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84 | 2004 |
|
Dr Salman Razvi Dr Jolanta Weaver
| Subclinical hypothyroidism and cardiovascular risk | 2004 |
|
Dr Jolanta Weaver
| Subclinical hypothyroidism and cardiovascular risk [1] (multiple letters) | 2004 |
|
Dr Jolanta Weaver
| The Prospective Pioglitazone Clinical Trial in Macrovascular Events (Proactive) | 2004 |
|
Dr Jolanta Weaver Dr Salman Razvi
| Withdrawal of anti-thyroid drugs (ATD) in a retrospective analysis of patients treated for Graves’s thyrotoxicosis. | 2004 |
|
Dr Jolanta Weaver
| Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL study | 2003 |
|
Dr Jolanta Weaver
| Losartan Reduces the Cost Associated with Diabetic End-stage Renal Disease | 2003 |
|
Dr Bakri Saeed Dr Jolanta Weaver
| Comparison of two direct methods for HDL-chlesterol measurement with an indirect precipitation method in diabetic patients | 2002 |
|
Dr Jolanta Weaver
| Influence of Growth Hormone on Accretion of Bone Mass | 2002 |
|
Dr Jolanta Weaver
| MicroAlbuminuria Reduction with Valsartan in patients with type 2 diabetes mellitus | 2002 |
|
Javed Sultan Dr Bakri Saeed Dr Jolanta Weaver
| Serum fructosamine is a marker of 5-year risk of developing diabetes mellitus in patients exhibiting stress hyperglycaemia | 2002 |
|
Dr Bakri Saeed Dr Jolanta Weaver
| Severe hyponatraemia: investigation and management in a district general hospital | 2002 |
|
Dr Jolanta Weaver
| Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course | 2001 |
|
Dr Jolanta Weaver
| The influence of gender on the short and long term effects of growth hormone replacement on bone metabolism and bone density in hypopituitary adults: 5 year study | 2001 |
|
Dr Mark Dobson Dr Chris Redfern Professor Nigel Unwin Dr Jolanta Weaver
| The N363S polymorphism of the glucocorticoid receptor: Potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus | 2001 |
|
Professor Roy Taylor Dr Jolanta Weaver
| Appropriate insulin regimes for type 2 diabetes: A multicenter randomized crossover study | 2000 |
|
Professor Roy Taylor Dr Jolanta Weaver
| Appropriate Insulin Regimes for Type 2 Diabetes: a multicenter randomized crossover study | 2000 |
|
Dr Jolanta Weaver
| The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) | 2000 |
|